Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Factor‐inhibiting hypoxia‐inducible factor (FIH) is an Fe(II)/2‐oxoglutarate‐dependent dioxygenase that acts as a negative regulator of the hypoxia‐inducible factor (HIF) by catalysing β‐hydroxylation of an asparaginyl residue in its C‐terminal transcriptional activation domain (CAD). In addition to the hypoxia‐inducible factor C‐terminal transcriptional activation domain (HIF‐CAD), FIH also catalyses asparaginyl hydroxylation of many ankyrin repeat domain‐containing proteins, revealing a broad sequence selectivity. However, there are few reports on the selectivity of FIH for the hydroxylation of specific residues. Here, we report that histidinyl residues within the ankyrin repeat domain of tankyrase‐2 can be hydroxylated by FIH. NMR and crystallographic analyses show that the histidinyl hydroxylation occurs at the β‐position. The results further expand the scope of FIH‐catalysed hydroxylations.Database 
The coordinates for the structure have been deposited in the Protein Data Bank in Europe (PDBe; under accession code 2y0iStructured digital abstract FIH and TNKS‐1 hydroxylate by enzymatic study (View Interaction 1, 2) FIH and Tankyrase‐2 bind by x‐ray crystallography (View interaction) FIH and Tankyrase‐2 hydroxylate by enzymatic study (View Interaction 1, 2, 3) FIH and TRPV4 hydroxylate by enzymatic study (View interaction) GABPB2 and FIH hydroxylate by enzymatic study (View interaction)

Original publication




Journal article


The FEBS Journal



Publication Date





1086 - 1097